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Abstract: Mast cells (MCs) are primarily resident hematopoietic tissue cells that are localized at
external and internal surfaces of the body where they act in the first line of defense. MCs are found
in all studied vertebrates and have also been identified in tunicates, an early chordate. To obtain a
detailed insight into the biology of MCs, here we analyzed the transcriptome of MCs from different
mouse organs by RNA-seq and PCR-based transcriptomics. We show that MCs at different tissue
locations differ substantially in their levels of transcripts coding for the most abundant MC granule
proteins, even within the connective tissue type, or mucosal MC niches. We also demonstrate that
transcript levels for the major granule proteins, including the various MC-restricted proteases and the
heparin core protein, can be several orders of magnitude higher than those coding for various surface
receptors and enzymes involved in protease activation, as well as enzymes involved in the synthesis
of heparin, histamine, leukotrienes, and prostaglandins. Interestingly, our analyses revealed an
almost complete absence in MCs of transcripts coding for cytokines at baseline conditions, indicating
that cytokines are primarily produced by activated MCs. Bone marrow-derived MCs (BMMCs) are
often used as equivalents of tissue MCs. Here, we show that these cells differ substantially from tissue
MCs with regard to their transcriptome. Notably, they showed a transcriptome indicative of relatively
immature cells, both with respect to the expression of granule proteases and of various enzymes
involved in the processing/synthesis of granule compounds, indicating that care should be taken when
extrapolating findings from BMMCs to the in vivo function of tissue-resident MCs. Furthermore, the
latter finding indicates that the development of fully mature tissue-resident MCs requires a cytokine
milieu beyond what is needed for in vitro differentiation of BMMCs. Altogether, this study provides
a comprehensive quantitative view of the transcriptome profile of MCs resident at different tissue
locations that builds nicely on previous studies of both the mouse and human transcriptome, and
form a solid base for future evolutionary studies of the role of MCs in vertebrate immunity.
Keywords: transcriptome; mRNA; mast cell; tryptase; chymase; serine protease; FcεRI; heparin;
histamine
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1. Introduction
Mast cells (MCs) are primarily known for their prominent role in immunoglobulin E (IgE)-mediated
allergies [1,2]. However, they are evolutionary old and humans with a complete lack of MCs have not
been identified, indicating an important physiological role of these cells. They are found in all studied
vertebrates, and MC-like cells have also been identified in tunicates, a chordate, which represents an
early evolutionary branch leading to all vertebrates, including mammals [3]. Mast cells most likely act
as early sentinel cells, inducing inflammation and attracting other inflammatory cells to the area of
inflammation. They are primarily resident hematopoietic tissue cells that are distributed along both
external and internal surfaces of the body where they act in the first line of defense [1,2]. Mast cells are
frequently found in the connective tissue of the skin and around blood vessels and nerves, as well as in
the mucosa of the airways and intestines. Mature MCs are generally not found in the circulation. Two
main types of MCs have been identified both in rodents and humans: Connective tissue MCs (CTMCs)
and mucosal MCs (MMCs). Connective tissue mast cells are, as the name implies, primarily found in
the connective tissue and in the peritoneal cavity whereas MMCs are mainly found in the intestinal
mucosa of mice and rats and to a lesser extent in the lungs [4–9].
Mature MCs store large numbers of cytoplasmic granules that are rapidly exocytosed following
activation. The majority of proteins found in these granules are serine proteases, which can generally
be subdivided into chymases and tryptases [10–13]. Chymases are chymotrypsin-like and cleave
substrates after aromatic amino acids whereas tryptases are trypsin-like in their specificity, with a
preference for Arg and Lys in the P1 position [10–13]. Very high amounts of these proteases are
found in MCs, where the levels can reach 35% of the total cellular protein [14]. Phylogenetic analyses
of the chymases have led to the identification of two distinct subfamilies, the α-chymases and the
β-chymases [6,13,15]. Connective tissue mast cells also express an MC-specific carboxypeptidase-
carboxypeptidase A3 (Cpa3). These proteases have been shown to inactivate snake, bee, and scorpion
toxins; regulate blood pressure by angiotensin II generation; and control inflammation by cleaving
a selective panel of cytokines [1,12,16–20]. Mast cell proteases likely have several other important
physiological functions, including connective tissue turnover and regulating coagulation [21,22].
A potential role of the mouse MC tryptase (Mcpt6) to link innate and adaptive immunity in the chronic
phase of Trichinella spiral infection has also been observed [23].
Mast cell granules also contain high levels of heavily sulfated, and thereby negatively charged,
glycosaminoglycans, such as heparin or chondroitin sulfate, and also large amounts of vasoactive low
molecular weight compounds, including histamine and serotonin [14,24–27]. Mast cells also express a
number of cell surface receptors and other molecules, of which many are MC specific or restricted to a
few cell types. Such important receptors are the high affinity receptor for IgE (FcεRI) and the receptors
for stem cell factor (SCF) and interleukin -3 (IL-3) [28,29]. Connective tissue mast cells and MMCs
show major differences in their expression of granule proteases and also in their levels of receptors and
in numerous other aspects, indicating that they have, at least partly, different physiological functions.
To obtain a multi-faceted view of the phenotype of mouse MCs, here we performed a transcriptome
analysis of purified mouse peritoneal MCs and analyzed MCs from other tissues for the expression
MC-restricted compounds. By using a larger number of cells, as opposed to single cell analysis,
we also increased the fidelity of the study to obtain a highly variable estimate of 20% to 30% of the top
transcripts and a good quantitative estimate of the transcription levels of approximately all 21,000
mouse genes. Single cell analysis, with 1 to 1.5 million reads per cell, and analysis of the combined
information from more than 50 cells may give similar data. However, no such information is available
for a more detailed comparison.
Our results showed that MCs of different tissue locations are highly specialized, differing
substantially in their expression of major granule compounds and enzymes involved in the processing
of such compounds. This analysis has also resulted in the identification of a number of interesting
genes expressed at much higher levels in MCs compared to the other 12 different tissues included in
this study. Analyses of the roles of these newly identified proteins in MC biology may also give new
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insights into the complex physiological roles of this medically important cell. This detailed analysis of
the MC transcriptome, and the abundance and heterogeneity of MCs in various mouse organs, can
also serve as a solid base for future studies concerning the roles of MCs in vertebrate immunity.
2. Materials and Methods
2.1. Mice
Female BALB/c mice were purchased from Taconic Biosciences ((Europe) Ejby, Denmark) and
maintained at the animal facility in the Biomedical Center (Uppsala University) or the Swedish
Veterinary Institute (Uppsala, Sweden). The animal experiments were approved by the local ethical
committee (Uppsala djurförsöksetiska nämnd; Dnr 5.8.18-05357/2018).
2.2. Generation of Bone Marrow-Derived MCs (BMMCs) and the effect of LPS Stimulation
Bone marrow cells were isolated from the femur and tibia of mice and grown in Dulbecco’s
modified Eagle’s medium (Sigma-Aldrich, Saint Louis, MO, USA) containing 30% WEHI-3B-conditoned
medium, 10% heat-inactivated fetal bovine serum (BSA) (Gibco, Carlsbad, CA), 100 U/mL penicillin,
100 µg/mL streptomycin, 2 mM L-glutamine (all from Sigma-Aldrich, Saint Louis, MO, USA), and
10 ng/mL IL-3 (PeproTech, Rocky Hill, NJ, USA). The medium was changed twice every week and
cells were cultured at a concentration of 0.5 × 106 cells/mL in a humidified 37 ◦C incubator with 5%
CO2 for at least 4 weeks to obtain mature and pure BMMCs. The cells were divided into two separate
fractions, one was directly frozen in liquid nitrogen for the preparation of total RNA and the second
was incubated in the above medium with the addition of 1 µg/mL of LPS per ml for 4 h, after which
the cells were pelleted and frozen in liquid nitrogen for subsequent RNA preparation.
2.3. Peritoneal Cell Extraction and Sorting of Peritoneal Mast Cells
For the extraction of peritoneal cells, mice were euthanized by isoflurane overdose and neck
dislocation, the abdominal skin was removed, and 9 mL of ice-cold phosphate-buffered saline (PBS)
was injected into the peritoneal cavity. After shaking the abdomen, peritoneal lavage fluid was
collected, and the cells were pelleted by centrifugation at 400× g for 10 min. The cells were resuspended
in magnetic-activated cell sorting (MACS) buffer, containing 0.5% BSA in PBS pH 7.2, and 2 mM
EDTA, followed by incubation with 20 µL of anti c-kit MicroBeads (Miltenyi Biotec, Bergish Gladbach,
Germany). After 30 min, cells were washed, resuspended in MACS buffer, and passed through an
LS column (Miltenyi Biotec, Bergish Gladbach, Germany). Magnetically labeled (c-kit+) cells were
collected and used for RNA isolation and assessment of mast cell purity. Alternatively, to enhance the
purity of peritoneal MCs, collected peritoneal cells were incubated in the first step with 1 µL of primary
PE-Cy5-conjugated anti-lineage antibodies CD3 (17A2), CD4 (GK1.5), CD8b (eBioH35-17.2), CD11b
(M1/70), CD19 (ebio1D3), B220 (RA3-6B2), Gr-1 (RB6-8C5), and TER-119 (TER-119). After 20 min,
the cells were washed, resuspended in MACS buffer, and incubated with 20µL Anti-PE-Cy5 MicroBeads
(Miltenyi Biotec, Bergish Gladbach, Germany). After 30 min, cells were washed, resuspended in MACS
buffer, and passed through an LD column (Miltenyi Biotec, Bergish Gladbach, Germany) according
to the manufacturer’s instructions. Subsequently, the unlabeled (Lin−) cells were collected, washed,
and in the second step incubated with 20 µL of anti c-kit MicroBeads for 30 min. After washing,
cells were resuspended in MACS buffer and passed through an LS column (Miltenyi Biotec, Bergish
Gladbach, Germany). The unlabeled cells were discarded while magnetically labeled (Lin− c-kit+)
cells were collected and used for RNA isolation and assessment of mast cell purity. The anti-lineage
antibodies were purchased from BD Biosciences (Franklin Lakes, NJ, USA) or eBioscience (Hatfield,
United Kingdom).
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2.4. Image Analysis
The magnetically sorted single run CD117+ cells and the Lin− CD117+ cells were cytospun onto
glass slides using a Shandon Cytospin 2 (Thermo Fisher Scientific, Inc., Waltham, MA, USA) and were
allowed to dry before staining with toluidine blue using a standard protocol to assess the purity of
sorted Lin− CD117+ MCs. The cells were imaged using a Nikon Eclipse Ni-U microscope (100× or
200× magnifications).
2.5. RNA Isolation
RNA isolation from purified cell fractions: Total RNA was prepared from MACS-sorted cells,
cultured BMMCs plus 4-h LPS-treated cells using the Nucleospin RNA kit (from Macherey-Nagel,
Germany), according to the manufacturer’s recommendations. The RNA was eluted with 30 µL of
DEPC-treated water, and the RNA concentration was determined by using a Nanodrop ND-1000
(Nano Drop Technologies, Wilmington, Delaware, USA). The integrity of the RNA was confirmed by
visualization on 1.2% agarose gels using ethidium bromide staining.
RNA isolation from tissue: Ear, lungs, brain, tongue, heart, liver, kidney, pancreas, duodenum,
proximal part of the colon, spleen, and uterus tissues were dissected from the mouse. Immediately
after removal, the tissues were frozen in liquid nitrogen, and made into a fine powder by grinding
with a pestle and mortar. The tissue powder was then used for total RNA isolation using the protocol
described above.
2.6. Analysis of the Transcriptome by RNA-Seq and by the Thermo Fisher Ampliseq Chip and PCR-Based
Method
Total RNA from the different cell fractions and whole tissues were used for transcriptome
analyses (GATC-Biotech, Ebersberg, Germany). mRNA was purified by poly-A selection following
fragmentation of the RNA and sequencing of 30 million fragments was performed. Individual read
lengths of around 50 to 100 nucleotides were then matched against a reference transcriptome library.
The FPKM values were normalized based on the total number of reads and sent to us as a large Excel
file with all the different cell and tissue samples in one file for easier comparison. The number of reads
per gene was, for the RNA-seq data from GATC, adjusted to the transcript length as longer transcripts
generate more fragments per mRNA and therefore a higher number of reads. Following the sorting of
the 33,915 different transcripts from the most highly expressed to the lowest, we manually went through
the entire list to identify the MC-specific highly expressed genes and the genes that were markedly more
highly expressed in MCs compared to other tissues. The results from the RNA seq analysis matched
well with previous cDNA library screenings and also with the Thermo Fisher chip-based Ampliseq
transcriptomic platform (Ion-Torrent next-generation sequencing system- Theromofisher.com). The
Thermo Fisher mouse Ampliseq transcriptome analysis platform is based on the purification on a chip
of the individual mRNAs (as cDNAs), which are then PCR amplified and sequenced individually. The
RNA is not fragmented but copied into cDNAs before binding to the chip. In the Ampliseq analysis,
every mRNA is read only once and the number of reads then corresponds to the expression level more
directly. Here, as for the RNA seq analysis, all the data from 16 different samples were sent to us as a
large Excel file containing all the transcripts for all the 16 samples in one file, which enabled an easy
comparison of the transcript levels between cell fractions and tissues. Following the sorting of the
23,931 different transcripts from the most highly expressed to the lowest, we manually went through
the entire list to identify the MC-specific highly expressed genes and the genes that were markedly
more highly expressed in mast cells compared to other tissues. In total, 265+ such genes were identified
for the pure MC preparation and all of these genes are listed in the Supplementary Material, with the
tissue and the expression level in that tissue that showed the second highest expression of this gene
being named in the table for an easier comparison.
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3. Results
3.1. Preparation of RNA from Tissues and Purified Peritoneal Cell Fractions
To study the total transcriptome of MCs, we sought to obtain pure populations of cells. One of
the best sources of MCs in mice is the peritoneal cavity, where MCs represent ~1% to 2% of the cells.
Peritoneal MCs are almost identical in their phenotype to classical skin MCs concerning their major
granule protease content, and both of these MC populations are classified as CTMCs. However, they
seems to differ in the expression levels of a few other proteins, including Mrgprb8 and 13, AdamtsS1
and 5, Sox3, CD59a, and CD34, which indicate that we cannot take them as direct equivalents [30].
Other cells of the peritoneum are mainly macrophages and B cells, which constitute approximately
60% and 35%, respectively, of the entire peritoneal cell population. Mast cells were purified by positive
selection with magnetic cell sorting (MACS) using an anti-c-kit (CD117) reacting monoclonal antibody.
Total RNA was prepared from this cell preparation and also from in vitro-differentiated mouse bone
marrow-derived MCs (BMMCs) grown in the presence of recombinant IL-3 for 4 weeks, and from total
mouse ear and total mouse lungs. These RNA preparations were subjected to transcriptome analyses
by two methods: (1) RNA-seq methodology, which involves mRNA purification and fragmentation,
cDNA synthesis, and sequencing 30 million reads on these fragments. The reads were then normalized
to the length of the individual mRNAs and listed as fractions of the entire transcriptome; and (2)
the mouse Ampliseq transcriptome analysis platform, based on the purification of cDNA copies of
individual mRNAs on a chip, followed by PCR amplification and individual sequencing. The RNA
is not fragmented, and generally every mRNA is therefore read only once, and the number of reads
will thereby directly match the expression. Bone marrow-derived mast cells, and the ear and skin
samples were of high purity. However, the peritoneal MCs were only 30% to 35% pure, which is why
we decided to focus on MC-specific transcripts in this initial analysis of peritoneal MCs (Figure 1A).
Figure 1. Toluidine blue staining of MACS-separated peritoneal cells. MACS-separated cells were
spun onto glass slides by cytospin centrifugation and were stained with toluidine blue. (A) the c-kit+
cells from the first purification. (B) the Lin−/ckit+ cells from the second, purer, preparation. Both were
used for the transcriptome analysis.
3.2. Analysis of Transcript Levels in Peritoneal MCs
The data from the transcriptome analysis of the preparation from mouse peritoneal MCs was
arranged (Table 1), with a focus on the granule proteins, the enzymes involved in the processing of
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granule compounds and on MC-specific cell surface receptors. From this preparation, we also made
an estimate of the difference in the abundance between house-keeping genes and cell type-specific
transcripts. This was done only for the GATC RNA seq, since this method is completely unbiased.
The house-keeping genes included different ribosomal proteins, elongation factors, β-actin, and a
number of proteins involved in general cell metabolism. When examining the top 100 expressed
transcripts in the peritoneal MCs and MCs from the skin and the lungs, approximately 80 of them
represented house-keeping genes. A calculation of the transcriptomes of the MCs and the different
tissues (skin and lungs), based on the 300 top transcripts, indicated that the house-keeping genes
accounted for 60% to 80% of the total mRNA pool of a cell or tissue, with the remaining transcripts
being tissue specific (data not shown). From the RNA seq data, it was apparent that the most abundant
granule proteins constitute the majority of the cell type-specific transcripts. These included the various
granule proteases, which could individually account for several percent of the total MC transcriptome.
In the tables, the results from both the RNA seq analysis and the PCR-based (Ampliseq) analysis are
presented. This data from the independent approaches matched remarkably well; the total counts
vary due to differences in the total number of normalized reads, but it was clear that the relative
abundances between individual transcripts were in very good agreement. Two individual samples
from the RNA-seq analysis are listed in Table 1 to study the reproducibility of the analysis. As can be
seen from the table, the two independent runs give almost identical values, showing that the analysis
is stable and reliable.
The major cell-specific transcripts of the peritoneal MCs were four different proteases, including
the serine proteases Mcpt4, Mcpt5, and Mcpt6, and the MC-specific carboxypeptidase Cpa3 (Table 1).
Mcpt4 is the major chymotryptic enzyme of CTMCs [6,31]; Mcpt5 is the alpha chymase, which
has evolved into an elastolytic enzyme in rodents [32]; and Mcpt6 is the major mouse MC tryptic
endopeptidase [33]. In addition to these serine proteases, the peritoneal MCs expressed relatively
high levels of Cpa3. All other proteases were expressed at very low levels, almost two orders of
magnitude lower than the major protease transcripts (Table 1). Mcpt7, the second MC tryptase,
was expressed at a level of 2% compared to Mcpt5 (Table 1). Cathepsin G, a chymotryptic enzyme
expressed at high levels in human neutrophils, was expressed at a level of 1.2% compared to Mcpt5.
Granzyme B, a serine protease primarily expressed by cytotoxic T cells, was expressed at a level of
~0.4% in comparison with Mcpt5 (Table 1). All other granzymes (A, K, C, D, E, F, and G) were almost
undetectable (Table 1). Cathepsin C, the enzyme responsible for N-terminal processing of the majority
of the different granule-stored serine proteases, was also expressed at a relatively low level: 0.9% to
2.5% in comparison with Mcpt5, depending on the method used (RNA-seq or Ampliseq) (Table 1).
One of the most characteristic receptors of MCs is the high affinity receptor for IgE, FcεRI. This
receptor has three different subunits that are all encoded by separate genes: The α-, β-, and γ-chains.
The α-chain, which is essentially MC and basophil specific, was expressed at approximately 3% or
0.8% of the Mcpt5 levels, respectively, as determined by the two different techniques (Table 1). The
receptor for SCF, c-kit, was expressed at approximately half the level of the IgE receptor α-chain (1.5%
of Mcpt5 levels) (Table 1). The IL-3 receptor was expressed at even lower levels (~0.5% of the Mcpt5
levels) (Table 1).
When examining a panel of different cytokines, including IL-4, IL-5, IL-6, IL-18. and IL-15,
we noted extremely low levels of the corresponding transcripts (Table 1). Out of these cytokines, only
IL-15 was expressed at levels above background (0.14% of the Mcpt5 level) (Table 1).
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Table 1. Transcript levels for granule proteases, cell surface receptors, and enzymes involved in the
production and processing of the granule components in mouse peritoneal MCs from BALB/c mice.
The number of normalized reads for the proteases is given in actual numbers (obtained from GATC
biotech and SciLife Thermo Fisher Ampliseq analyses). Two independent GATC RNA seq runs were
performed. For comparison, the relative levels in % to the most highly expressed transcripts (Mcpt5)
are indicated in red.
GATC-RNA Seq Ampliseq
Proteases
Cma1 (Mcpt5) 17072 17116 35388
Mcpt4 (mMCP-4) 16668 16752 31292
Tpsb2 (Mcpt6) 14244 13548 39628
Cpa3 (CPA-3) 9564 9844 13892
Tpsab1 (Mcpt7) 352 348 (2%) 96
Mcpt9 (mMCP-9) 12 12 0
CtsG (CTS-G) 216 204 (1%) 512
Mcpt8 (mMCP-8) 8 12 12
CtsC (DPP) 148 152 (0.5%) 876
Gzm B 68 72 (0.4%) 236
Gzm A 8 12 12
Gzm K 0 0 2.4
Gzm M 2 4 1.6
Gzm N 0 0 1.2
Gzm C 0 0 0.8
Gzm D 0 0 0.4
Gzm E, F, G 0 0 0
Receptors
FcεRI alpha 480 500 (3%) 252
c-kit 248 252 (1.5%) 720
IL-3R 112 100 (0.5%) 80
Heparin and Histamine synthesis
Srgn (Serglycin) (920) (900)(22%) (2800)
Ndst2 464 564 (2.7%) 1688
Ndst1 68 64 264
Hdc (Histidine decarb.) 300 292 (1.5%) 600
Cytokines & Chemokines
IL-4 12 12 9.2
IL-5 0 0 0
IL-15 12 8 48
IL-18 52 52 0
IL-6 8 8 8
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3.3. Analysis of In Vitro Differentiated BMMCs
Cells from the bone marrow of BALB/c mice were grown in the presence of 30% conditioned media
from WEHI-3B cells, which contains IL-3, and with a supplement of 10 ng/mL of recombinant IL-3 for 4
weeks. The resulting cell culture consisted of almost 100% pure MC-like cells, i.e., representing BMMCs.
Almost all cells stained positively for alcian blue and toluidine blue, although not as strongly as the
peritoneal MCs. The BMMCs were analyzed with both RNA seq and Ampliseq. In the BMMCs, high
transcript levels were seen for two of the four major protease transcripts, Mcpt5 and Cpa3 (Table 2).
In contrast, very low levels of Mcpt4 and also low levels of Mcpt6 were detected (Table 2). Interestingly,
a very high level of transcript corresponding to the FcεRI α-chain was seen (Table 2). For this gene,
we noted that the RNA-seq and Ampliseq approaches produced different results. With the RNA-seq,
the level of the α-chain was more than 50% of the Mcpt5 level, whereas the Ampliseq data indicated
~10%, which was still very high compared to the peritoneal MCs where the levels were approximately
3% and 0.8%, respectively, for the two independent technologies (Table 2).
Table 2. Transcript levels for granule proteases, cell surface receptors, and enzymes involved in the
production and processing of the granule components in mouse bone marrow-derived MCs (BMMCs;
in vitro differentiated; from BALB/c mice). The number of normalized reads for the proteases is given
in actual numbers (obtained from GATC biotech and SciLife Thermo Fisher Ampliseq analyses). Two
different growth conditions were tested: unstimulated and stimulated by 1µg/mL of lipopolysaccharide
(LPS) for 4 h. The fold increases in expression levels (for Gzm B and Gzm C) after LPS stimulation and
the levels (in %) of the FcεRI alpha chain expression compared to Cpa3 are marked in red.
GATC-RNA Seq Ampliseq
Normal +4 h LPS Normal +4 h LPS
Proteases
Cma1 (Mcpt5) 7102 7618 15683 17413
Mcpt4 (mMCP-4) 5 22 7 34
Tpsb2 (mMCP-6) 746 896 3119 3345
Cpa3 (CPA-3) 13430 11990 22478 17717
Tpsab1 (Mcpt7) 72 241 54 190
Mcpt9 (mMCP-9) 0.9 2.4 0 0
CtsG (CTS-G) 7 9 18 30
Mcpt8 (mMCP-8) 24 25 46 36
Mcpt1 (mMCP-1) 15 64 15 56
Mcpt2 (mMCP-2) 1 10 1.2 15
CtsC (DPP) 51 44 288 243
Gzm B 161 700 386 1900 (4-5x)
Gzm A 0 0 0 0
Gzm K 0 0 0.3 0.9
Gzm M 0.2 0.2 0.3 0.6
Gzm N 0 0 0.1 0.1
Gzm C 0.1 106 0.1 110 (1000x)
Gzm D 0 0 0 0.8
Gzm E 0 0 0.1 0.1
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Table 2. Cont.
GATC-RNA Seq Ampliseq
Normal +4 h LPS Normal +4 h LPS
Receptors
FcεRIα 4918 3280 1631 1342 (10–70%)
c-kit 318 307 833 931
IL-3R 30 22 25 22
IL1RL1 (ST2) 1039 1310 4582 5859
CsfRI2B (coβIL-3 GM-CSF) 1851 1855 3485 3499
FcεRIγ 468 432 1815 1545
CD23 0.3 0.5 0 0
FcγRIII 132 135 538 433
FcγRIIb 33 32 40 39
FcγRI 1 1 5 1
CD63 1894 2153 2699 3624
Integrin alpha2b 495 474 2472 2003
Heparin and Histamine
synthesis + Transcr. Factors
Srgn (Serglycin) 2637 3139 8107 9990
Ndst2 188 210 820 874
Ndst1 13 7 60 30
5-Lipoxygenase (Alox5) 1029 767 2757 2016
Histidine decarb. (Hdc) 19 99 48 279
Tryp. Hydroxylase (Tph1) 711 1368 2370 4148
Cyp11a1 1840 2041 6422 6252
Slc18a2 (Monoamine transp.) 2218 2348
GATA1 95 81 296 267
GATA2 594 900 5205 7289
GATA3 4 3 14 12
We also tested the effect of bacterial lipopolysaccharide (LPS) on the transcript levels in BMMCs.
After a 4-h incubation with 1 µg/mL LPS, relatively small changes in transcript levels were seen.
However, major changes were observed for a few transcripts, including Mcpt4 with a 4- to 5-fold
increase, Mcpt7 and Mcpt2 with 4-fold increases, Mcpt1 with a 10- to 12-fold increase, granzyme B
with a 4- to 5-fold increase, and a 1000-fold increase for granzyme C (Table 2). However, it should be
noted that the baseline levels of granzyme C were very low (Table 2). We also examined the expression
of Toll-like receptors (TLRs) in the BMMCs. Using Ampliseq, we only detected significant levels of
TLR-4, with 134 and 76 reads for BMMCs and BMMCs-LPS-4 h, respectively, and very low levels of
TLR-1, -2, and 6 (six reads or lower).
3.4. Analysis of the Transcript Levels in Mouse Ear with a Focus on MC Transcripts
To assess the MC phenotype in various tissues, we performed an analysis of mouse connective
tissue and lungs. To assess MCs in a connective tissue environment, ear tissue was selected. To evaluate
the phenotype of ear MCs, the levels of MC-specific transcripts in the ear was assessed and was related
to major transcripts of the ear. As expected, the most abundant transcripts of the ear were keratins.
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We detected high levels of at least 12 different keratins in the ear, of which keratin 10, 2, and 14 were the
most abundant (Table 3). We also detected relatively high levels of α-actin and troponin C2, revealing
the presence of muscular tissue. The different MC-specific transcripts, including proteases, receptors,
and processing enzymes, were then used to determine the amount and types of MCs in the ear tissue.
The analysis showed that CTMCs were by far the dominating MC subtype in the ear, represented
by high levels of transcripts for Mcpt4, Mcpt5, Mcpt6, and Cpa3. In contrast, transcripts for MMC
proteases (Mcpt1 and Mcpt2) were essentially undetectable (Table 3), indicating that MMCs were not
populating the ear. Interestingly, the levels of Mcpt4 were two-fold higher than Mcpt5, which indicated
that the MCs of the ear were more differentiated compared to the peritoneal MCs (Table 3). It was also
noted that BMMCs expressed extremely low levels of Mcpt4 in comparison with the ear skin MCs
(~0.01% of the Mcpt5 levels) (Table 2). The fact that BMMCs are typically grown in the presence of IL-3
or SCF, or a combination of them, and that cells obtained from such cultures are relatively immature,
indicates that additional unknown factors, which are essential for the development of fully mature
MCs, are present in both the peritoneum and skin. Two individual samples from the Ampliseq analysis
for the ear and the lung are listed in Tables 3 and 4 to study the reproducibility of the analysis. As can
be seen from the tables, the two independent runs give very similar values, showing that the Ampliseq
analysis is also stable and reliable.
We also considered the overall proteolytic environment of the skin. We found the expression of a
large number of different kallikreins, of which many were expressed at high levels: Primarily kallikrein
7, 5 10, 8, and 11. We also found the expression of several matrix metalloproteases (MMPs), primarily
MMP-2, -14, and -3. To control these, there are a number of protease inhibitors, and we found that many
of these were expressed at high levels. These included a large panel of serpins (23 members), whereas
low levels of SLPI expression were seen (data not shown). Altogether, these analyses showed that a
complex network of proteases and protease inhibitors resides in the skin tissue, including significant
levels of various MC proteases.
We also found low levels of three defensins, Def-b6 (40 and 28 reads), Def-b1 (90 and 91 reads),
and Def-b14 (17 and 23 reads), by the Ampliseq analysis.
Table 3. Levels of major transcripts in the ears of BALB/c mice. The number of normalized reads for
each of the proteases is given in actual numbers (obtained from GATC biotech and SciLife Thermo
Fisher Ampliseq analyses). Two independent Ampliseq runs were performed. Note that the levels of
Mcpt4 were very high in the skin compared to the peritoneal MCs.
GATC-RNA Seq Ampliseq
Major skin transcripts
Keratin 10 9490 13724 14386
Keratin 2 6121 15412 18444
Keratin 14 3938 7855 7670
Keratin 5 2726 5304 5637
Keratin 15 1277 2897 2733
Keratin 1 1093 2373 2673
Keratin 77 617 2199 2430
Keratin 79 525 2321 2362
Keratin 17 492 878 780
Keratin 80 171 1453 1574
Loricrin (Lor) 4029 14026 9840
Calmodulin 4 3133 2895 3821
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Table 3. Cont.
GATC-RNA Seq Ampliseq
Mast cell transcripts
Mcpt4 (mMCP-4) 110 148 206
Cma1 (Mcpt5) 52 75 79
Tpsb2 (Mcpt6) 38 92 93
Cpa3 (CPA-3) 34 48 42
Mcpt7 (mMCP-7) 8 1.4 1.5
Mcpt2 (mMCP-2) 0.2 0 0
Mcpt1 (mMCP-1) 0.1 0 0
Mcpt8 (mMCP-8) 0 0 0
CtsG (CTS-G) 2 3 6
Srgn (Serglycin) 18 38 48
FcεRIα 0.6 0.1 0.5
FcεRIγ 18 61 56
Ndst2 7 41 45
Ndst1 13 76 83
Granzymes
Gzm C 2 0.95 1.7
Gzm M 3 0.95 1.2
Gzm A 0.5 0.2 0.2
Gzm B 0.15 0.1 0.4
Gzm D 0 0 0
Table 4. Levels of major transcripts and MC-specific transcripts in lung (BALB/c mice). The number
of normalized reads for each of the different proteases is given in actual numbers (obtained from
GATC biotech and SciLife Thermo Fisher Ampliseq analyses). Two independent Ampliseq runs
were performed.
GATC-RNA Seq Ampliseq
Major Lung transcripts
Scgb1a1 (Uteroglobin) 16 31234 35193
Scgb3a2 1011 1263 1288
Scgb3a1 260 522 522
Scgb1c1 23 39 30
Sftpc (Surfactant) 21382 20059 23191
Sftpa1 1073 9154 9384
Sftpd 434 73 67
Tmsb4x (Thymosin beta 4) 6430 5597 4519
Lyz2 (P-Lysozyme) 4843 10629 10721
Lyz1 (M-Lysozyme) 1131 990 962
Cbr2 (Carbonyl reductase, NADPH2) 2911 6181 4566
Sparc (Osteonectin, BM40) 652 4577 4276
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Table 4. Cont.
GATC-RNA Seq Ampliseq
Inmt (Amine-N-methyltransferase) 1947 4363 4730
Sptbn1 (Spectrin beta chain) 280 3742 3432
Epas1 (Endothelial PAS domain cont. prot 1) 642 3710 3439
Cyp2f2 (Cytochrome P450 2F2) 1378 3437 2651
Sec14l3 (Sec 14 like lipid transport) 431 1640 1583
Mast cell transcripts
Cma1 (Mcpt5) 3.7 8 8
Cpa3 (CPA-3) 3.6 1 1
Mcpt4 (mMCP-4) 1 2 3
Tpsb2 (Mcpt6) 0.8 2 2
Mcpt7 (mMCP-7) 0.16 0.1 0
Mcpt8 (mMCP-8) 0.7 3 3
Mcpt1 (mMCP-1) 0.15 0.3 0.4
Mcpt2 (mMCP-2) 0.15 0.4 0.1
3.5. Analysis of the Transcript Levels in Mouse Lungs with a Focus on MC Transcripts
To study the number and types of MCs in the lungs, we analyzed the total lung transcriptome.
Similar to our assessment of the ear, we used MC granule proteases and MC-specific receptors as
primary tools to determine the presence and phenotype of lung MCs. As previously shown by
immunohistochemistry, the number of MCs in a normal healthy lung is very low [34,35]. We detected
transcripts representative of CTMCs, MMCs, and basophils in the lungs as exemplified by Cpa3,
Mcpt5, Mcpt6, and Mcpt4 for CTMCs, Mcpt1, and Mcpt2 for MMCs and Mcpt8 for basophils (Table 4).
However, the levels of all of these proteases were extremely low, indicating low numbers of MCs and
basophils in the lungs. As expected, the major transcripts of the lungs were for the surfactant-like SFTc,
and also very high levels of both lysozyme 1 and 2. High lysozyme levels are most likely important for
bacterial clearance of the lungs. We found the presence of transcripts for both mouse lysozyme genes,
Lyz1 and Lyz2. However, very low levels of defensin transcripts were observed using the Ampliseq
analysis: Only three of these were expressed: Def b2 (11 and 14 normalized reads), Def b1 (1 and 2
normalized reads), and Def b14 (1 and 2 normalized reads), which should be compared to values of
over 10,000 reads for Lyz1 (Table 4).
3.6. Analysis of Transcript Levels in Peritoneal MCs of a Higher Purity to Obtain a More Complete Picture of
the MC Transcriptome
To obtain a more complete picture of the mouse MC transcriptome, we performed several
additional attempts to obtain pure peritoneal MC populations, which resulted in the use of a protocol
involving several steps of magnetic cell sorting (MACS), resulting in a purity of over 95% as well as a
sufficient amount of cells to obtain a good coverage of the entire transcriptome (Figure 1B). Based on
cell morphology, the few percent of contaminating cells appeared to be primarily B cells, which have a
very different transcriptome from MCs and therefore impose little risk of errors in the identification
of transcripts.
Total RNA was purified from pure peritoneal MCs and from 10 additional mouse tissues, both to
identify transcripts that were highly expressed in MCs compared to other tissues and to obtain a more
complete picture of the presence of MCs in different tissues. The selected tissues were the brain, liver,
kidney, duodenum, pancreas, tongue, heart, proximal part of the colon, uterus, and spleen. Based on
the previous validation, we used only one method (Ampliseq) to study these tissues.
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Similar to the initial analysis of the peritoneal MCs, we decided to focus on the granule proteases
(Supplementary Material Table S1) as well as the cell surface receptors (Supplementary Material
Table S3).
However, in this new analysis, we also included protease inhibitors (Supplementary Material
Table S2), cell adhesion molecules (Supplementary Material Table S10), enzymes involved in heparin,
histamine and lipid mediator synthesis (Supplementary Material Table S11), cytokines and chemokines
(Supplementary Material Table S12), transcription factors expressed at higher levels in MCs compared
to other tissues (Supplementary Material Table S13), RNA binding molecules and splicing factors
(Supplementary Material Table S14), molecules involved in cell division (Supplementary Material Table
S15), molecules involved in cell signaling and intracellular granule transport (Supplementary Material
Tables S16 and S17), and finally on other category proteins (Supplementary Material Table S18).
The top transcripts were, as in the previous analysis, the granule proteases (Mcpt4, Mcpt5, Mcpt6,
and Cpa3; Supplementary Material Table S1). They were expressed more than 100 times higher than
most other MC-specific or MC-related transcripts. The only other highly expressed transcripts were the
core protein for heparin and chondroitin sulfate (serglycin) (8905 reads) and FcεR-gamma (2913 reads).
The top transcript was Mcpt6, with 67.773 normalized reads (Supplementary Material Table S1).
Mcpt5, Mcpt4, and Cpa3 were in the same range, with 45221, 33.040, and 45.604 normalized reads,
respectively (Supplementary Material Table S1). Mcpt7 was expressed almost 200 times lower
(386 reads) and cathepsin G (1111 reads) approximately 60 times lower than Mcpt6 (Supplementary
Material Table S1). Granzyme B was also present but at a level more than 100 times lower than Mcpt6
(581 reads; Supplementary Material Table S1). All the other granzymes as well as the mucosal MC
proteases Mcpt1 and 2 were almost undetectable (Supplementary Material Table S1). Tryptase gamma,
a membrane-bound tryptase, was also expressed at a very low level (123 reads; Supplementary Material
Table S1). We also observed a low level of the basophil-specific protease Mcpt8 (38 reads; Supplementary
Material Table S1 [8,36]. Interestingly, we detected relatively high levels of some additional proteases
not generally considered as MC-related, namely cathepsin E (1248 reads), urokinase (661 reads),
tripeptidyl peptidase (TPP) (588 reads), ADAMTS 9 (370 reads) and ubiquitin carboxyl-terminal
hydrolase (198 reads) (Supplementary Material Table S1).
The major protease inhibitors found in the MC transcriptome were Serpin b1a, Serpin b6a, Lxn,
and Cystatin F (1037, 127, 185, and 181 reads, respectively) (Supplementary Material Table S2).
Of the immunoglobulin receptors, we primarily detected FcεRI alpha (345 reads) (Supplementary
Material Table S5) and FcγRIII (752 reads) (Supplementary Material Table S3). The inhibitory receptor
FcγRIIb was expressed at a lower level (91 reads) (Supplementary Material Table S3). The signaling
component of FcεRI and FcγRIII, i.e., FcεR-gamma, was relatively highly expressed (2913 reads) and
the FcεRI beta chain was expressed at somewhat lower levels (1297 reads) (Supplementary Material
Table S3). Most of the other Fc receptors were expressed at almost undetectable levels, except the very
interesting immunoglobulin-related receptor, MC immunoglobulin-like receptor 1 (MilR1; 283 reads).
This receptor, which has been shown to have an important dampening role during MC activation,
was expressed at least 100 times higher in MCs than in any of the other tissues analyzed (Supplementary
Material Table S3) [37].
Several receptors to cytokines or other mediators were found to be highly expressed in MCs
compared to all other tissues. These receptors included the SCF receptor (c-kit; 1198 reads), the IL-33
receptor (ST2; 1693 reads), the IL-3 receptor alpha chain (159 reads), and the common beta chain of the
IL-3, IL-5, and GM-CSF receptors (CSF2Rb; 415 reads) (Supplementary Material Table S4).
High expression of the interferon alpha/beta receptor beta chain (Ifnar2) in comparison with other
tissues was also seen (453 reads) (Supplementary Material Table S4). A number of other interferon
receptors were identified that were also present in other tissues at similar levels, including the alpha
chain of the alpha/beta interferon receptor (90 reads) and both the alpha and beta chains of the interferon
gamma receptor (228 and 115 reads, respectively) (Supplementary Material Table S4).
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Relatively high levels of expression were seen for of a number of the recently discovered receptors:
The MAS-related GPR members, including Mrgprb2, Mrgprb1, Mrgpra4, Mrgprb8, Mrgprb4, and
Mrgprx1 (899, 366, 155, 19, 11, and 13 reads, respectively) (Supplementary Material Table S5).
Mrgprb2 is known to induce non-IgE receptor-mediated responses to substance P and other small
cationic substances [38–40].
The endothelin receptor A (Ednra; 892 reads) was also expressed at higher levels in MCs versus
all other tissues analyzed (Supplementary Material Table S6).
The beta-adrenergic receptor (Adrb2) was also expressed higher in MCs versus other tissues
(631 reads; Supplementary Material Table S6). The ATP receptors P2rx7 and P2rx1 were also highly
expressed in MCs compared to other tissues (571 and 327 reads, respectively) (Supplementary Material
Table S6). ATP has recently been shown to have potent MC-activating properties through several
mechanisms, including the P2rx7 and P2rx1 receptors [41]. CD200r3 was expressed 100- to 1000-fold
higher in MCs than in other tissues (275 reads) (Supplementary Material Table S8).
CD200r3 has been shown to be an activating receptor for MCs [42]. High levels of CD34 and
CD81 were also seen (332 and 1475 reads, respectively) (Supplementary Material Table S8). We also
observed relatively high levels of CD55 (decay accelerating factor or DAF), CD274 (PD-L1), and CD276
(B7-H3) (439, 200, and 163 reads, respectively) (Supplementary Material Table S8). These latter genes
were expressed at higher levels in MCs compared to other tissues (Supplementary Material Table S8).
Significant levels of the Ig domain-containing and inhibitory receptor CD300a were also detected (184
reads) (Supplementary Material Table S8). We did not detect expression of CD40L and very low levels
of CD40 (Supplementary Material Table S8). Very low levels of TLRs were also seen, with TLR-4 being
the most abundant (61 reads) (Supplementary Material Table S9), and the only other TLR detected was
TLR-13 (13 reads) (Supplementary Material Table S9).
Interestingly, we also detected low levels of expression for a large number of olfactory receptors
and also the vomeronasal receptors in MCs but not in any of the other tissues analyzed. However, the
expression levels for these were very low, ranging from 18 to 2 reads (Supplementary Material Table
S9); the biological relevance of this finding is thus questionable. Interestingly these were also identified
as MC expressed in an important study of the MC and basophil transcriptomes by Dwyer et al. [30].
Several other receptors, of which a few have been described as MC-related, were also expressed at
comparably high to very high levels compared to other tissues. The most striking of these was a member
of the GDNF receptor family, Gfra2 (2016 reads), that binds GDNF and neurturin, Fxyd5/dysadherin
(1850 reads) and Lat2 (linker of activation of T-cell family members; 1588 reads) (Supplementary
Material Tables S4 and S7). Lat2 has previously been shown to have a central role in MC activation
upon IgE receptor crosslinking [43]. Interestingly, we also observed relatively high levels of Tarm1,
the T cell-interacting activating receptor on myeloid cells protein 1 (156 reads; Supplementary Material
Table S7).
Tarm1 was much more highly expressed in MCs compared to all other tissues analyzed.
We also examined the different cell adhesion molecules expressed by peritoneal MCs
(Supplementary Material Table S10). Some of these were selectively expressed by MCs whereas
others were highly expressed in both MCs and other tissues. In MCs, we detected integrins a4, b1,
b2, a2b, a9, a5, am, b7, and a2 (404, 444, 388, 266, 217, 135, 113, 211, and 137 reads, respectively)
(Supplementary Material Table S10). We also detected relatively high levels of the P selectin ligand
CD162 (369 reads) and CD43/sialophorin (134 reads) (Supplementary Material Table S10). Interestingly,
we also detected the expression of mucin 13 (147 reads) (Supplementary Material Table S10). For mucin
13, only duodenum and tongue were higher (520 and 1178 reads, respectively) (Supplementary Material
Table S10). Very high expression of the GPCR family member of adhesion receptors, Adgre5/CD97
(2839 reads), was also observed (Supplementary Material Table S10).
The next sets of genes to be analyzed were the enzymes and transporters involved in heparin,
histamine, and lipid mediator synthesis. As mentioned previously, the most highly expressed of these
genes was serglycin, the heparin core protein (8905 reads) (Supplementary Material Table S11). Of the
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deacetylases involved in sulfation of the carbohydrate backbone of heparin, NDST-2 was essentially
MC-specific and quite abundant (1112 reads), whereas the other NDSTs (NDST-1, 3) were almost
absent in MCs (Supplementary Material Table S11). A number of other genes that are directly or
indirectly involved in heparin, chondroitin sulfate, or heparan sulfate biosynthesis were also expressed
at relatively high levels in the MCs compared to most other tissues (Supplementary Material Table
S11). The most highly expressed of these were N-acetylgalactose amine 4-sulfate 6-O-sulfotransferase
(Chst15) (448 reads); carbohydrate sulfotransferase 11 (Chst11) (216 reads); idunorate-2-sulfatase
(Ids) (657 reads); heparan sulfate 6-O-sulfotransferase 2 (Hs6st2) (152 reads); N-acetylgalactose
aminide alpha-2-6-sialyltransferase 3 (St6galnac3) (290 reads); N-sulfoglucoseamine sulfohydrolase
(Sgsh) (215 reads); exostosin 1 (Ext1), the endoplasmic reticulum-resident type II transmembrane
glycosyltransferase involved in the chain elongation step in heparan sulfate synthesis (254 reads); and
glucosamine-fructose-6-phosphate aminotransferase isomerizing 1 (Gfpt1) (398 reads) (Supplementary
Material Table S11).
For histamine synthesis, we found high levels of histidine carboxylase (936 reads) and the
monoamine transporter (Slc18a2; transports amines, including histamine) (861 reads) (Supplementary
Material Table S11). For serotonin synthesis, we noted high levels of tryptophan hydroxylase (Tph1;
550 reads) and the serotonin transporter (Slc6a4; 1468 reads), which is involved in reabsorption of
released serotonin after granule release (Supplementary Material Table S11).
For enzymes involved in lipid mediator synthesis, we saw a number of relatively highly
expressed genes, including phospholipase A2 (PLA2 g7; 1116 reads), 5-lipoxygenase (Alox5; 486
reads), prostaglandin D synthase (Hpgds; 450 reads), and lysophosphatidylcholine acetyltransferase
2 (Lpcat2; 177 reads; of importance for Platelet activating factor (PAF) synthesis) (Supplementary
Material Table S11).
With respect to the cytokines and chemokines expressed by peritoneal MCs, we noted low or very
low levels of most of the classical interleukins, with detectable expression only of IL-4, IL-13, IL-15,
IL-18, IL-1α, IL-6, and IL-12b (13, 4, 8, 18, 6, 12, and 9 reads, respectively) (Supplementary Material
Table S12). However, we saw substantial levels of two chemokines, Ccl-2 and Ccl-6 (397 and 188 reads,
respectively), as well as three cytokines involved in fibroblast growth and differentiation: Fibrosin
(Fbrs), TGF-β1, and TGF-β activator (Nrros) (355, 550, and 180 reads, respectively) (Supplementary
Material Table S12). We also detected low expression of hepatocyte growth factor (Hgf) and oncostatin
M (Osm) (59 and 38 reads, respectively) (Supplementary Material Table S12). Numerous interferons
were also found at very low levels, including Ifna9, Ifna2, Ifna4, Ifnb1, Ifna16, Ifna12, Ifna5, Ifne, Ifnab,
and Ifna14 (8, 7, 7, 6, 6, 3, 2, 2, 2, and 2 reads, respectively) (not listed in a table).
Several transcription factors were expressed at much higher levels in MCs compared to other
tissues. Two of the most well characterized factors for MC development, GATA-2 and MITF, were
found among the most highly expressed (2272 and 370 reads, respectively) (Supplementary Material
Table S13) [44,45]. In contrast, GATA-1 and GATA-3 were expressed at relatively low levels (74 and
27 reads, respectively) (Supplementary Material Table S13). This is also is in line with previous
investigations where GATA-1 is primarily expressed in erythrocytes and platelets, and GATA-3 in
NK cells, T cells, and the placenta. A number of other transcription factors were highly expressed in
peritoneal MCs compared to other tissues. Among these were Runx1 and Runx3 (638 and 409 reads,
respectively) (Supplementary Material Table S13). We also detected extremely high levels of Myb (2490
reads) and very high levels of a number of additional transcription factors, including the stress-induced
transcription factor CREB3l1 (992 reads); the zinc finger, E box, and homeobox protein Zeb2 (1019
reads); the transcription factor TOX2 (568 reads); Fli1/ERGB (473 reads); CREBbp, a CREB binding
factor (426 reads); Crtc3 (CREB-regulated transcription activator 3; 369 reads); Pnn (pinin transcription
factor E box binding (CAGGTG); 423 reads); Ldb1 (LIM domain binding transcription factor; 423
reads); Cbfa2t3 (transcriptional regulator interacting with HDACs and Runx; 418 reads); Cited4
(Cbp/P300 interacting transactivator with Glu/Asp-rich carboxy-terminal domain 4; 277 reads); Atf7ip
(activating transcription factor 7-interacting protein 1; 357 reads); Kmt2c (lysine N-methyltransferase
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2C; 343 reads); Meis2 (a homeobox protein; 300 reads); Ankrd12 (ankyrin repeat domain-containing
protein 12; 269 reads); Tal1 (basic helix-loop-helix transcription factor; 246 reads); Samsn1 (Sam
domain-containing negative regulator of B cell activation; 187 reads); Pu.1/Spi1 (205 reads); and
LAT (111 reads). Interestingly, several of these transcription factors have never been linked to MC
development. A number of other transcription factors were also present but at similar levels as in
other tissues, including Ikaros (113 reads), and a number if IRFs, including IRF-9, -2, -1, -7, -5, -8,
-6, -3, and -4 (101, 100, 81, 65, 60, 40, 37, 25, and 11 reads, respectively) (not listed in the table) [44].
A number of STATs were also found, including STAT-3, -6, 2, -5b, 5a, and -4 (256, 196, 112, 56, and 17
reads, respectively) (not listed in the table) [44]. The STATs were also present in most other tissues.
These transcription factors may still be of major importance for the phenotype of the MC, although the
majority of them are most likely of lower importance for determining the path during differentiation
from the hematopoietic stem cell to become a fully mature MC.
A number of RNA-binding proteins, splicing factors, and proteins involved in cell division were
also found to be highly expressed in MCs compared to the other tissues (Supplementary Material
Tables S14 and S15).
As a next step, we focused on proteins involved in cell signaling and vesicular transport. The main
such signaling components and vesicular transport proteins are listed in Supplementary Material Tables
S16 and S17. High MC-level proteins found included several phospholipase C isoforms, primarily
the B and D types (1001 and 350 reads, respectively), Rgs13 (regulator of G protein signaling; 289
reads; a signaling molecule shown to be involved in IgE-mediated responses), as well as Syk, a central
player for IgE receptor signaling [46]. Several of the components known to be involved in IgE receptor
signaling, including Lyn, VAV, and Grb2, were also expressed in MCs [46]. Lyn (44 reads) and VAV (204
reads) are also expressed in several other hematopoietic cells at similar levels, and Grb2 (445 reads)
was also expressed relatively high in other tissues.
Finally, we noted high expression in MCs of a number of proteins with functions not within the
previous categories or with unknown functions. The most striking of these were Lgals (galectin 1),
which has immunosuppressive functions (2116 reads), Lrmp (Tap-independent peptide transporter
for MHC1; 406 reads), C2 (complement factor 2; 159 reads), and ERV3 (an endogenous full-length
retrovirus [47]; 141 reads) (Supplementary Material Table S18).
3.7. Analysis of MC-Related Transcript Levels in Mouse Brain, Liver, Kidneys, Tongue, Heart, Pancreas,
Duodenum, Proximal Part of the Colon, Total Spleen, and the Uterus.
To obtain a more comprehensive view of the MC transcriptome, we included 10 additional
tissues. In these analyses, we observed that the MC transcript levels were very low in many tissues,
including the brain, liver, kidneys, colon, pancreas, and heart. In these tissues, the levels of all the
CTMC proteases (Mcpt4-6, Cpa3) were below 2.5 reads, and the MMC proteases (Mcpt1 and -2) were
undetectable. The levels of the MC proteases were much higher in the duodenum, where the MMC
proteases dominated and only low levels of the CTMC proteases were detected (23 and 6 reads for
Mcpt1 and 2, respectively). The opposite situation was seen in the tongue, where the CTMC proteases
dominated, with only low levels of the MMCs proteases (71, 36, 116, 37, 3, and 0.6 reads for Mcpt4,
Mcpt5 and Mcpt6, Cpa3, Mcpt1, and Mcpt2, respectively). Interestingly, relatively high levels of the
CTMC proteases were seen in the uterus (14, 8, 25, and 10 reads for Mcpt4, -5, and -6, and Cpa3,
respectively), but no transcripts for the MMC proteases could be detected. In the spleen, we noted low
levels of both CTMC and MMC proteases (4, 3, 5, 7, 2, and 0.5 reads for Mcpt4, Mcpt5, Mcpt6, Cpa3,
Mcpt1, and Mcpt2, respectively).
As a validation of our data, all of the studied tissues showed expression of tissue-specific
transcripts, with the intestinal digestive enzymes, chymotrypsinogen, pancreatic lipase, pancreatic
carboxypeptidases, trypsinogen, and RNases in the pancreas, albumin as the top transcript in the liver,
myoglobin, myosin regulatory chain, myosin alpha chain and cardiac muscle alpha actin in the heart,
and myelin basic protein as one of the top transcripts in the brain.
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4. Discussion
Analyses of total transcriptomes by different techniques offers powerful tools in the analyses
of cells, and also allows studies of the development of cells and tissues. For such studies, several
alternative techniques have recently been developed. However, remarkably few quantitative studies
using such tools have been published. In general, only the fold increase or decrease of transcripts
during stimulation is presented and absolute values of expression are rarely given. Data are often
also not presented by real numbers but rather as heatmaps, which lack information concerning the
abundance of the various transcripts. The presentation of only a fold change can also be misleading
concerning their relevance. Frequently, transcript levels can increase 10- or even 100-fold, but when
their baseline expression is starting at an extremely low level, it is questionable if such increases are
biologically relevant. For example, here we showed that the expression of granzyme C increases
by almost 1000-fold after LPS stimulation of BMMCs. However, the original levels were very low
(0.1 reads), and we can therefore not be certain that the increase in granzyme C has any biological
impact. For this reason, we propose that the absolute values of gene expression (rather than fold
changes) are more informative concerning the biological impact. In a hallmark study by Dwyer et al.,
many MC- and basophil-specific transcripts were identified [30]. Many of the transcripts we describe
in this study were also identified in that study. However, it is important to note that the former study
by Dwyer et al. did not provide absolute values of expression. Almost all the MC-related transcripts
are marked in the same bright red in their heatmaps even if they differ by two to three orders of
magnitude in expression levels in our analysis. One of the aims of this study was therefore to generate
a deeper understanding of the MC transcriptome by providing data on the absolute expression levels
for the various transcripts. This study also involved many more transcripts than the previous study
and identified many new proteins that may have major impacts on MC biology, which could be the
target for future studies. In contrast to previous studies, this study also involved the analysis of the
abundance and heterogeneity of MCs in 12 different mouse organs.
We previously performed a study on rat peritoneal MCs where we measured the absolute values of
expression. At that time, the only reliable available method was the use of unamplified cDNA libraries.
We therefore hybridized individual filters with a panel of probes able to obtain accurate quantitative
information concerning transcript levels for approximately 26 different transcripts (Figure 2) [7].
However, this technique is extremely time consuming and labor intensive, which hampered a more
extensive analysis. However, by using the new transcriptome platforms it is now possible to obtain
reliable information of almost all the 21,000 genes of the mouse or the human transcriptome, and also
information on the abundance of different splice variants. Despite this, these technologies are still
relatively poorly validated, mainly because appropriate reference libraries have not yet been established.
Our earlier cDNA library data was therefore valuable as a reference material for the optimization and
validation process in this study. The possibility of using two independent technologies with the same
sample also increased our confidence that the data obtained was reliable. By using the information
obtained by both the RNA-seq as well as the chip and PCR-based transcriptome analyses, we can now
confirm that the general pattern observed from our previous studies using the unamplified cDNA
libraries holds remarkably well.
The transcript levels for the major MC granule proteins are remarkably high, in the range of several
percent of the total mRNA pool of the cell [7]. The levels of the most characteristic MC cell surface
receptors, including FcεRI, c-kit, the IL-33 receptor, and the IL-3 receptor, were, in general, close to two
orders of magnitude lower than for the major granule proteins. The expression of processing enzymes,
including cathepsin C (involved in activation of the granule serine proteases), enzymes involved in
histamine, serotonin, and heparin synthesis, histidine decarboxylase, tryptophane hydroxylase, and
NDST-2, was also relatively low. An estimate of the house-keeping genes indicated that they represent
a large fraction of the total transcriptome. A calculation of the transcriptomes of the MCs and the
different tissues (skin and lungs), based on the 300 top transcripts, indicated that the house-keeping
genes accounted for 60% to 80% of the total mRNA pool of a cell or tissue, with the remaining transcripts
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being tissue specific. Among the latter, a few major transcripts accounted for the absolute majority,
where in the case of the MCs, these transcripts coded for the major granule proteases and the heparin
core protein (serglycin).
Figure 2. Transcript levels for MC-related genes in rat peritoneal MCs from an earlier study using an
unamplified cDNA library [7]. The number of plaques per 100,000 clones were calculated for each of the
listed transcripts. These values give an approximate value for the transcript abundance. Approximately
30% of the clones were empty indicating that the relative abundance of for example RMCP-1 was not
2.5% but closer to 3.5% of the total transcriptome.
During MC development, the first proteases to appear are Mcpt5 and Cpa3, whereas Mcpt4 and
Mcpt6 appear later and are therefore markers for more mature MCs. An interesting finding in this
study was the very low levels of Mcpt4 expression in BMMCs grown in the presence of IL-3. The levels
of Mcpt4 were ~1000 times lower than in peritoneal and skin MCs. Mast cells grown in the presence
of SCF, a major MC growth factor, have also been shown to express low levels of Mcpt4, indicating
that yet unknown factors are needed to obtain full differentiation into mature tissue-resident MCs [45]
The level of Mcpt6 was also considerably lower in BMMCs compared to the peritoneal or skin MCs,
whereas the IgE receptor α-chain was expressed very highly in BMMCs compared to peritoneal or
skin MCs, indicating an immature phenotype of BMMCs. Interestingly, the addition of SCF to the
MC cultures seems, at least in C57BL/6 mice, to upregulate Mcpt6 but not to increase the levels of
Mcpt4 [45].
When examining the transcriptome of the ear skin and the tongue, we noted that the skin MCs
were almost exclusively of the CTMC subtype. The skin and tongue MCs expressed remarkably high
levels of four different proteases, of which three were serine proteases and one a carboxypeptidase:
Mcpt4, Mcpt5, Mcpt6, and Cpa3 (Table 3). We detected almost no expression of the mucosal MC-specific
proteases Mcpt1 and Mcpt2, and no expression of the basophil-specific protease Mcpt8 (Table 3).
When assessing the lungs, we found very low levels of MC- and basophil-related transcripts,
confirming the previous findings of such levels in mouse lungs [34,35]. The situation is somewhat
different with human lungs, which have relatively high numbers of MCs [48]. This is very relevant
for the discussion when using mice as a model for studying the impact of MCs on lung function.
However, recently it has been found that MC numbers increase quite substantially in the mouse lung
upon different viral infections or allergen challenge [49,50]. Viral infections also lead to increased MC
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numbers in human lungs [51]. During these infections, it seems that primarily MCs of the mucosal
type increase and that this increase is transient, which most likely originates from MC precursors
originating from the bone marrow [49,50]. Quite dramatic increases in MC numbers can also appear
in other tissues upon infection. Massive increases in mucosal MC numbers are generally observed
upon intestinal worm parasite infections [9,52]. An interesting observation comes from Schistosoma
mansoni-infected BALB/c mice, where a strong upregulation of both MMC and CTMC proteases occurs
in the intestinal region, and a very strong upregulation of the basophil-specific transcript for Mcpt8
is seen the lungs, indicating a marked infiltration of basophils [8]. These findings indicate that both
MCs and basophils can fluctuate quite dramatically in numbers upon various viral, parasite, and
bacterial infections.
By extended analyses of a more than 95% pure MC population from the peritoneum and a
simultaneous analysis of 10 additional tissues, we could look deeper into the MC transcriptome and
also obtain a more general picture of the presence of MCs and their subtypes in a large panel of
different tissues. As for the initial analysis, we noted that the four CTMC proteases are the major
tissue-specific transcripts of the CTMC. Next was the core protein for heparin and chondroitin sulfate
synthesis, serglycin. When examining the surface receptors, the cell adhesion molecules, and the
enzymes involved in histamine, leukotriene, prostaglandin, and PAF synthesis, we noted expression of
at least two orders of magnitude lower than for the highest expressed genes. Interestingly, we also
saw that FcγRIII was more abundant than the IgE receptor, and that the inhibitory receptor FcγRIIb
showed relatively low expression compared to the other two dominating Ig receptors. Also of note,
the Ig receptor-related receptor allergin-1 or Milr1 was expressed at a level similar to the alpha chain
of the IgE receptor (345 and 283 reads, respectively). This receptor may, together with the inhibitory
receptor FcγRIIb, control signaling from the IgE receptor [37]. This analysis has also made it possible
to examine in more detail the presence of known and previously unidentified transcription factors,
signaling molecules, and molecules involved in vesicular transport. These analyses identified a number
of genes that had previously not been linked to MCs, for example, Fxyd5, mucin 13, Myb, Zeb2, Tox2,
Runx3, and Fli1. We also found several that have previously been identified as being MC expressed,
including Gfra2, histamine receptor 4, and CREB3l1 [30]. Further work will be required to establish the
importance of these genes in MC development/function.
Most of the immune-related cytokines, including interleukins and colony-stimulating factor, were
expressed at very low levels. They were expressed higher in MCs than in other tissues but were
nevertheless very low, indicating that MCs primarily produce cytokines upon activation. The low level
of cytokine mRNA thereby confirmed our previous findings from rat peritoneal MCs [7] (Figure 2) and
has recently also been confirmed in another study of the effect on chromatin opening by various MC
stimuli, where the levels of cytokine mRNA were found to be very low in the absence of stimulatory
signals [53]. Interestingly, and in contrast to the interleukins, some chemokines were expressed at
relatively high levels in MCs, including Ccl2 and Ccl6. Ccl2, also named monocyte chemoattractant
protein 1 (MCP1), may have a role in maintaining sufficient numbers of monocytes/macrophages in
the tissue, also during non-inflammatory conditions. Three cytokines of importance for fibroblast
growth and differentiation were also found to be relatively highly expressed: TGF-β, fibrosin 1, and
TGF-β activator (Nrros), indicating a role of MCs in connective tissue homeostasis. Mast cells may
also participate in the normal connective tissue turnover via their proteases. These can be released
by piecemeal degranulation during non-inflammatory conditions and can, by degrading fibronectin
and activating pro-collagenases, remove damaged connective tissue components and provide space
for new such components produced by fibroblasts. The production of fibroblast-activating cytokines
by MCs may thus be important for tissue maintenance. In line with this, Mcpt4 knockout mice
accumulate excessive connective tissue in an age-dependent manner [31,54]. TGF-β also has a potent
anti-inflammatory effect and MCs may thereby have a potent anti-inflammatory role in the tissue,
in addition to their pro-inflammatory impact. It is also interesting to note that MCs express high levels
of galectin 1, which also has anti-inflammatory properties, and suggests that this expression also adds
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to the potential anti-inflammatory effects of MCs [55]. The detection of very high levels of the initial
enzyme in the steroid hormone synthesis pathways (P450scc) was unexpected. The expression of
P450scc in MCs was at least 300 times higher than in any of the other tissues studied. However, low
levels of the other enzymes in steroid hormone production were detected, indicating that the first
product in this cascade, pregnenolone, may have a physiological role in the connective tissue.
Only very low levels of TLRs were observed. We only detected the expression of two TLRs,
TLR-4 and TLR-13, which indicates a low response by normal tissue MCs to TLR ligands during
non-inflammatory conditions. Very low levels of CD40 and the CD40 ligand were also observed,
indicating that MCs have a minor direct role in B-cell responses, as CD40-CD40L interaction is a key
component for such responses. However, cytokines produced by MCs during inflammatory conditions
may, if present in sufficient concentrations, have a role in isotype switch regulation. The expression of
complement factor 2 (C2) with 159 reads in MCs was also interesting, which was three times higher
than in the liver sample with 50 reads. Liver is thought to be the primary site for the production of
most complement and coagulation components, and this finding indicates that this is not the situation
for all of these factors and that MC actually can be an important production site for C2.
Concerning the role of transcription factors in MC and basophil development, several, including
GATA-2 and MITF, are well established as key regulators, and others, like IRF8, STAT5, and C/EBPa, are
also central to this process [44,45]. Here, we noted that GATA-2 and MITF are relatively MC specific,
whereas IRF8, STAT5, and C/EBPa were more broadly expressed, indicating that some factors may be
guiding whereas others are necessary as supporting factors. It will be interesting to determine the role
of several of the factors with high or medium MC specificity identified in this transcriptome analysis,
for example, Myb, Zeb2, Tox2, Runx3, CREB3l1, and Fli1, for their roles in MC development. Further,
a number of factors with a potential role in cell signaling, as well as the control of intracellular calcium
signaling and granule release, were identified. Some of these are already well characterized whereas
the roles of others in regulating MC function remain to be investigated.
It is apparent from this study that MCs express an extremely complex network of receptors,
signaling molecules, and transcription factors. High levels of expression were seen for the activating
receptors FcεRI, FcγRIII, and CD200R3, the Mas-related receptors (e.g., Mrgprb2), receptors for ATP,
and endothelin receptors. These activating receptors are in turn controlled by a number of negatively
acting receptors, including FcγRIIb, CD300a, and Allergin-1, as well as possibly by the soluble factor
galectin-1. TGF-β secreted by MCs also has an anti-inflammatory role. Interestingly, the neurotrophin
receptor Gfra2 was highly expressed in MCs, and one of its ligands, neuroturin, has been shown to
have potent anti-inflammatory effects [56]. Relatively high expression levels were also seen for PD-L1,
indicating that MCs also can have a dampening function on cytotoxic T cells (Supplementary Table S8).
The proteases released by MCs also regulate the activity of endothelin-1 and of a set of Th2-promoting
cytokines, including IL-18, IL-33, TSLP, IL-15, and IL-21, by cleavage. Endothelin-1 is inactivated
primarily by CPA3, whereas chymase cleaves IL-18, IL-33, and IL-15, and tryptase cleaves TSLP and
IL-21 [19,20,57].
Analysis of the different tissues for MC-specific protease transcripts also gave an insight into the
presence of MCs in different organs. Very low levels of MC-specific transcripts were seen in many
tissues, including the brain, liver, kidney, heart, pancreas, and colon. In contrast, relatively high levels
of transcripts corresponding to CTMCs were seen in the ear, tongue, and uterus, and high levels of
MMC transcripts were found in the duodenum. We observed relatively large amounts of a panel of
keratin transcripts in the tongue, indicating some similarities between the tongue and skin, which may
have a role in the preferential presence of CTMCs in these tissues. Interestingly, the keratin genes
expressed in the two tissues were quite different, with keratins 10, 2, and 14 dominating in the ear and
13, 4, and 16 dominating in the tongue.
As mentioned already in the beginning of the discussion, a large number of the above described
MC-related transcripts were also identified in the hallmark study by Dwyer et al. and in the very
important papers from the Immgen consortium [30,58] (www.immgen.org). The ones identified in
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these studies include Plau, Adamts9, C2, Hpgds, the Mrgpr receptor members, CD200r3, CD34, and
histamine receptor 4. In these studies, different MC proteases and IgE receptor components as well as
the enzymes involved in histamine and heparin synthesis and transport, the chemokine Ccl2, and also
a number of the abovementioned transcription factors and signaling molecules. including GATA-2
and MITF, were identified as being MC expressed. The coherence between these different studies
makes us confident that we now have a quite detailed view of the transcriptome of the mouse MC.
An important study of the human MC transcriptome has also been published by Motakis et al., which
makes it possible to look at similarities and differences between human and mouse MCs [59]. In this
study, the transcriptome of human skin MC was analyzed by deep-CAGE sequencing. In MCs isolated
from human skin without further culturing, high levels of transcripts for the human MC proteases,
including the β-tryptases, Cma1, and CPA3, and interestingly, almost four times higher levels of
cathepsin G transcripts than for the second most abundant MC protease, the β-tryptase, were found.
This in marked contrast to the mouse, where cathepsin G is expressed at a level of only 1% of the level
of the mouse tryptase Mcpt6 (Table 1). They also find very high levels of several of the important
cytokine receptors for MC development, including kit and IL1RL1(ST2), and also the α and β chains of
the IgE receptor (FcεRI). The levels of kit transcripts in these human MC were actually even higher than
the level of transcripts for the β-tryptase [59]. They also found high levels of the human counterpart
to the mouse substance P receptor Mrgprb2, the Mrgprx2 [59]. The levels of the different toll-like
receptors were also found to be very low in the human skin MCs, as we observed in the mouse [59].
So, although there are clear similarities, there are also major differences between mouse and human
MCs as, for example, the transcript levels of the receptors, which appear to be in the same range as the
proteases in human MCs whereas they are almost two orders of magnitude lower than the protease
transcripts in the mouse.
In conclusion, new methods for transcriptome analysis can now give us high quality, quantitative
information concerning the entire transcriptome in various tissues and cell preparations. These methods
can serve as powerful tools to study the biology and phenotype of a cell type or an organ. Additionally,
the use of tissue-specific expressed genes makes it possible to study individual cell populations within a
tissue without the need to purify them from the tissue, which reduces the error in the analysis resulting
from difficulties in obtaining quantitative recovery of minor cell populations. Here, these techniques
were used to obtain quantitative information concerning MCs in various tissues, high quality data on
types and numbers of these cells in different organs, and indications for still unknown tissue factors
that are of major importance for MC development. The immature phenotype of BMMCs, which are
often used as tissue equivalents in studies of MC biology, also raises questions of how relevant they
are for such studies. The detailed analysis of a relatively pure population of peritoneal MCs and its
comparison with transcript levels in 10 different mouse tissues also made it possible to identify a large
number of new MC-specific proteins, of which many may have a major role in MC biology. However,
in-depth analyses of the roles of these newly identified proteins in MC differentiation, inflammatory,
anti-inflammatory responses, and in normal tissue homeostasis will be needed before we have the
complete picture of their precise role in MC biology. This detailed quantitative analysis of the MC
transcriptome in the mouse and the abundance and subtypes of MC in different organs can also serve
as a solid base for future studies of the role of MCs in vertebrate immunity. As previously mentioned,
MC-like cells have been identified in early chordates, as represented by the sea squirt Ciona intestialis (a
tunicate) [3]. These cells have been shown to stain positive with toluidine blue, as mammalian MCs,
and to contain heparin and histamine, as well as expressing a serine protease with tryptic activity and
being able to produce prostaglandin D2 [60]. However, the relationship of this tryptic protease to
the human MC tryptase and mouse Mcpt6 or Mcpt7 is not yet established. Zebrafish MC-like cells
have also been shown to stain positive with toluidine blue, to express a carboxypeptidase that shows
38% identity with human CPA3 and 64% identity to human pancreatic CPA1, and to stain positive
for c-kit [61]. Zebrafish MC-like cells are also dependent on GATA2 and Pu-1 for their development,
similarly to mammalian MCs, but do not need GATA-1 [61]. Interestingly, zebrafish MC-like cells also
Cells 2020, 9, 211 22 of 25
express lysozyme C and MPO, two markers that are not normally associated with mammalian MCs
but instead are associated with neutrophils in humans, indicating that there are also clear differences
between fish and mammalian MCs [61]. A clearly identifiable homolog to the IgE receptor alpha chain
has also been identified in the opossum, a marsupial, with possible similar receptor components in the
platypus also [28]. However, it is not yet known if they are expressed in MCs. These studies show that
information is also starting to accumulate concerning MCs not only in humans, mice, and rats but
also other vertebrates. The recently developed transcriptome platforms can now be used to obtain a
more detailed picture concerning the evolution of MC and MC-like cells in different branches of the
vertebrate evolutionary tree. This detailed analysis of the mouse MC transcriptome can thereby be
used as a solid reference for such studies.
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